Sinopharm Group Co., Ltd. (SHTDY)
OTC
Real-time Data
01:30 PM
Day's Range
10.2152 wk Range
10.00Overview - SHTDY - Sinopharm Group Co., Ltd.
Key Statistics
Valuation
Enterprise Value
14.42B
P/E (Trailing)
‪6.23‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪0.52‬
EV / EBITDA
‪5.06‬
Profitability
Profit Margin
‪1.23%‬
Operating Margin
‪2.18%‬
Return on Assets
‪2.62%‬
Return on Equity
‪8.10%‬
Ownership
Shares Outstanding
3.12B
Float
254.92M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.44‬
50-Day Avg
‪10.76‬
200-Day Avg
‪12.27‬
Dividends
Payout Ratio
‪29.43%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SHTDY - Sinopharm Group Co., Ltd.
Peers - SHTDY - Sinopharm Group Co., Ltd.
Peer Comparison
Compared with companies in Medical Distribution listed on OTC.
Profile Summary - SHTDY - Sinopharm Group Co., Ltd.
About
Sinopharm Group Co., Ltd. is a leading player in China’s pharmaceutical and healthcare industries. As a vertically integrated conglomerate, its primary function is to manufacture, distribute, and retail a vast array of pharmaceutical products, including vaccines, medical devices, and traditional Chinese medicine.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
